Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cephalon Provigil Has 28% Awareness Among Primary Care Physicians

Apr 19 2004

• By The Pink Sheet

Related Content

Sepracor Estorra Is “Approvable” For Insomnia; Launch Goal Is Mid-Year

Mar 08 2004

Cephalon Launches Provigil Label Expansion; DTC Campaign Possible

Mar 08 2004

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window